(Q33174189)

23 July 2017

1 reference

title

Torsades de pointes ventricular tachycardia associated with overdose of astemizole (English)

1 reference

23 July 2017

0 references

1 reference

K A Rao

1

1 reference

23 July 2017

A Adlakha

2

1 reference

23 July 2017

B Verma-Ansil

3

1 reference

23 July 2017

T D Meloy

4

1 reference

23 July 2017

M S Stanton

5

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 June 1994

1 reference

23 July 2017

1 reference

23 July 2017

volume

69

1 reference

23 July 2017

issue

6

1 reference

23 July 2017

page(s)

589-593

1 reference

The pharmacological profile of a specific, safe, effective and non-sedative anti-allergic, astemizole

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962252-6

Torsade de pointes after astemizole overdose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962252-6

Astemizole-induced torsade de pointes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962252-6

Astemizole-induced ventricular arrhythmias: an unexpected cause of convulsions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962252-6

Giant U waves and associated ventricular tachycardia complicating astemizole overdose: Successful therapy with intravenous magnesium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962252-6

Accidental astemizole overdose in young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962252-6

Cardiotoxic effects of astemizole overdose in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962252-6

The long QT syndrome. Prospective longitudinal study of 328 families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962252-6

Arrhythmogenic effects of antiarrhythmic drugs: a study of 506 patients treated for ventricular tachycardia or fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962252-6

Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962252-6

Pharmacological characterization of cardiac histamine receptors: Sensitivity to H1- and H2-receptor agonists and antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962252-6

Dysrhythmias caused by histamine release in guinea pig and human hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962252-6

Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962252-6

The long QT interval syndrome. A Rosetta stone for sympathetic related ventricular tachyarrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962252-6

Torsades de pointes associated with drugs and toxins: recognition and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962252-6

10.1016/S0025-6196(12)62252-6

7 January 2021

Identifiers

DOI

1 reference

23 July 2017

1 reference